Amantea, D., Russo, R., Bagetta, G. and Corasaniti, M. T. (2005). From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens. Pharmacological Research, 52, 119–132.
Anstey, K. J., Cherbuin, N., Budge, M. and Young, J. (2011). Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obesity Reviews, 12, e426–437. doi:10.1111/j.1467-789X.2010.00825.x.
Atti, A. R., Palmer, K., Volpato, S., Winblad, B., De Ronchi, D. and Fratiglioni, L. (2008). Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project. Journal of the American Geriatrics Society, 56, 111–116. doi:10.1111/j.1532-5415.2007.01458.x.
et al. (2013). Moderate overweight is beneficial and severe obesity detrimental for patients with documented atherosclerotic heart disease. Heart, 99, 655–660. doi:10.1136/heartjnl-2012-303066.
et al. (1997). Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Molecular Pharmacology, 51, 535–541.
Boushey, C. J., Beresford, S. A., Omenn, G. S. and Motulsky, A. G. (1995). A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA, 274, 1049–1057.
Braak, H. and Braak, E. (1997). Staging of Alzheimer-related cortical destruction. International Psychogeriatrics, 9, 257–261; discussion 269–272.
Buchman, A. S., Schneider, J. A., Wilson, R. S., Bienias, J. L. and Bennett, D. A. (2006). Body mass index in older persons is associated with Alzheimer disease pathology. Neurology, 67, 1949–1954.
Buchman, A. S., Wilson, R. S., Bienias, J. L., Shah, R. C., Evans, D. A. and Bennett, D. A. (2005). Change in body mass index and risk of incident Alzheimer disease. Neurology, 65, 892–897.
Burns, J. M., Johnson, D. K., Watts, A., Swerdlow, R. H. and Brooks, W. M. (2010). Reduced lean mass in early Alzheimer disease and its association with brain atrophy. Archives of Neurology, 67, 428–433. doi:10.1001/archneurol.2010.38.
Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L. and Ueland, P. M. (1998). Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Archives of Neurology, 55, 1449–1455.
Collins, D. L., Neelin, P., Peters, T. M. and Evans, A. C. (1994). Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. Journal of Computer Assisted Tomography, 18, 192–205.
de Leon, M. J.
et al. (1988). Abnormal cortisol response in Alzheimer's disease linked to hippocampal atrophy. Lancet, 2, 391–392.
Enzi, G., Gasparo, M., Biondetti, P. R., Fiore, D., Semisa, M. and Zurlo, F. (1986). Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. American Journal of Clinical Nutrition, 44, 739–746.
et al. (1992). 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. Journal of Clinical Investigation, 89, 883–891.
Goldberg, A. P., Busby-Whitehead, M. J., Katzel, L. I., Krauss, R. M., Lumpkin, M. and Hagberg, J. M. (2000). Cardiovascular fitness, body composition, and lipoprotein lipid metabolism in older men. Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 55, M342–M349.
Gonzalez-Gross, M., Marcos, A. and Pietrzik, K. (2001). Nutrition and cognitive impairment in the elderly. British Journal of Nutrition, 86, 313–321.
Gray, S. L.
et al. (2013). Frailty and incident dementia. Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 68, 1083–1090. doi:10.1093/gerona/glt013.
Greco, S. J., Sarkar, S., Johnston, J. M. and Tezapsidis, N. (2009). Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells. Biochemical and Biophysical Research Communications, 380, 98–104.
Gustafson, D. (2006). Adiposity indices and dementia. Lancet Neurology, 5, 713–720. doi:10.1016/s1474-4422(06)70526-9.
Gustafson, D., Lissner, L., Bengtsson, C., Bjorkelund, C. and Skoog, I. (2004). A 24-year follow-up of body mass index and cerebral atrophy. Neurology, 63, 1876–1881.
Gustafson, D., Rothenberg, E., Blennow, K., Steen, B. and Skoog, I. (2003). An 18-year follow-up of overweight and risk of Alzheimer disease. Archives of Internal Medicine, 163, 1524–1528.
Harvey, J., Solovyova, N. and Irving, A. (2006). Leptin and its role in hippocampal synaptic plasticity. Progress in Lipid Research, 45, 369–378. doi:10.1016/j.plipres.2006.03.001.
Hogervorst, E., Bandelow, S. and Moffat, S. D. (2005). Increasing testosterone levels and effects on cognitive functions in elderly men and women: a review. Current Drug Targets: CNS and Neurological Disorders, 4, 531–540.
Jack, C. R. Jr., et al. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurology, 9, 119–128. doi:10.1016/s1474-4422(09)70299-6.
Kim, B. J., Lee, S. H., Jung, K. H., Yu, K. H., Lee, B. C. and Roh, J. K. (2012). Dynamics of obesity paradox after stroke, related to time from onset, age, and causes of death. Neurology, 79, 856–863. doi:10.1212/WNL.0b013e318266fad1.
Kim, J. S.
et al. (2005). Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification. NeuroImage, 27, 210–221.
Kopelman, P. G. (2000). Obesity as a medical problem. Nature, 404, 635–643.
et al. (1994). Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. International Journal of Obesity and Related Metabolic Disorders, 18, 207–202.
Lavie, C. J., Milani, R. V. and Ventura, H. O. (2009). Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. Journal of the American College of Cardiology, 53, 1925–1932. doi:10.1016/j.jacc.2008.12.068.
Lyttelton, O., Boucher, M., Robbins, S. and Evans, A. (2007). An unbiased iterative group registration template for cortical surface analysis. NeuroImage, 34, 1535–1544.
Macchi, G. (1989). Anatomical substrate of emotional reactions. In Squire, L. and Gainotti, G. (eds.), Handbook of Neuropsychology (pp. 283–303). Amsterdam: Elsevier.
et al. (2005). The relationship between testosterone and molecular markers of inflammation in older men. Journal of Endocrinological Investigation, 28, 116–119.
Morrison, C. D. (2009). Leptin signaling in brain: a link between nutrition and cognition?
Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1792, 401–408. doi:10.1016/j.bbadis.2008.12.004.
et al. (2005). Cardiovascular disease risk factors in habitual exercisers, lean sedentary men and abdominally obese sedentary men. International Journal of Obesity, 29, 1063–1069. doi:10.1038/sj.ijo.0803004.
Park, H. Y.
et al. (2010). Lung function, coronary artery calcification, and metabolic syndrome in 4905 Korean males. Respiratory Medicine, 104, 1326–1335.
Raji, C. A.
et al. (2010). Brain structure and obesity. Human Brain Mapping, 31, 353–364.
et al. (2012). The influence of optimal medical treatment on the ‘obesity paradox’, body mass index and long-term mortality in patients treated with percutaneous coronary intervention: a prospective cohort study. BMJ Open, 2, e000535. doi:10.1136/bmjopen-2011-000535.
Simpson, E. R.
et al. (1994). Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocrine Reviews, 15, 342–355.
Singh, V. K. and Guthikonda, P. (1997). Circulating cytokines in Alzheimer's disease. Journal of Psychiatric Research, 31, 657–660.
Sled, J. G., Zijdenbos, A. P. and Evans, A. C. (1998). A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Transactions on Medical Imaging, 17, 87–97.
et al. (2008). Relationship between body mass index and gray matter volume in 1,428 healthy individuals. Obesity (Silver Spring), 16, 119–124. doi:10.1038/oby.2007.4.
Teixeira, A. L.
et al. (2013). Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease. Neuromolecular Medicine, 15, 115–121. doi:10.1007/s12017-012-8201-2.
Thomas, T., Thomas, G., McLendon, C., Sutton, T. and Mullan, M. (1996). beta-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature, 380, 168–171.
et al. (2012). Levels of amyloid beta-42, interleukin-6 and tumor necrosis factor-alpha in Alzheimer's disease and vascular dementia. Neurochemical Research, 37, 1554–1559.
Vidoni, E. D., Townley, R. A., Honea, R. A. and Burns, J. M. (2011). Alzheimer disease biomarkers are associated with body mass index. Neurology, 77, 1913–1920.
Ward, M. A., Carlsson, C. M., Trivedi, M. A., Sager, M. A. and Johnson, S. C. (2005). The effect of body mass index on global brain volume in middle-aged adults: a cross sectional study. BMC Neurology, 5, 23.
Weiner, M. F., Vobach, S., Olsson, K., Svetlik, D. and Risser, R. C. (1997). Cortisol secretion and Alzheimer's disease progression. Biological Psychiatry, 42, 1030–1038.
WHO Expert Consultation (2004). Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet, 363, 157–163.
Wood, S. N. (2011). Fast stable restricted maximum likelihood and marginal likelihood estimation of semiparametric generalized linear models. Journal of the Royal Statistical Society. Series B, Statistical Methodology, 73, 3–36.